What it is
A blood-forming stem cell transplant replaces a person's blood-forming system with healthy blood-forming stem cells. These cells can come from bone marrow, from the bloodstream (peripheral blood stem cell transplant) or from donated umbilical cord blood. They are sometimes called bone marrow transplants, cord blood transplants or hematopoietic stem cell transplants.
People often look into this type of transplant when they or a loved one are dealing with conditions such as leukemia, lymphoma, sickle cell disease or aplastic anemia. Whether a transplant is appropriate is a decision for a licensed transplant physician after a full evaluation. It is not right for everyone.
On the FDA question, blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are the clearly FDA-approved use of stem cells. They are performed at hospitals and transplant centers under close medical supervision. This is very different from stem cell, MSC, bone marrow aspirate, adipose-derived, umbilical cord / Wharton's jelly or exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss. Those are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved stem cell clinics and products.
How it’s traditionally been approached
Traditionally, these transplants have been done in hospital-based transplant programs. Care teams usually include physicians, nurses, pharmacists, social workers and others. The process generally involves testing, matching a donor or using a person's own cells when appropriate, a preparation phase, the infusion of cells and a period of close monitoring afterward.
Because the procedure is intensive, it carries real risks. Reported risk categories include infection, immune reactions between donor and recipient cells, organ-related complications and side effects from the preparation phase. A transplant team weighs these against a person's condition and overall health, and explains them in the context of that individual's situation.
Many people also learn about related options during this process, including other treatments, supportive care and registered clinical trials. A transplant center can explain which of these fit a person's circumstances. Choosing among them is a medical decision that belongs with licensed clinicians.
How the right provider may help
The right provider may help by evaluating your situation, explaining whether a transplant is among the options, and describing what the process generally involves. A first visit is usually a conversation about health history, current treatment, test results and goals. It is not a promise of any outcome. A second opinion from another qualified team is a normal and reasonable step.
Good questions to ask include: What exactly is the product or cell source, and what is its FDA status? What are the specific risks for me? What is the realistic chance of benefit? What are the alternatives, including doing nothing? What is the total cost, including follow-up care and complications? Can I take time to decide and walk away at any point? These items also make a useful informed consent checklist, though this page is not a consent form.
Red flags when choosing a provider: guarantees of results; 'cure' or 'regrow' language; refusal to name the product or its FDA status; pressure to decide quickly; and discouraging a second opinion. Treatment abroad is materially higher risk because safety, sourcing and regulatory standards differ and a complication is harder to address from a distance. A vetted domestic provider is a safer first step. A registered clinical trial, searchable on ClinicalTrials.gov, is another route to legitimate experimental care.
The whole-person view
Facing a serious blood condition and a possible transplant affects the whole person. Body, mind and stress influence one another, and long treatment, uncertainty and time away from normal life can weigh on sleep, mood and energy. Caring for the whole person alongside medical care may be part of a steadier experience.
Some people explore body-based support such as Somatic Experiences to help with stress held in the body, and others find talk therapy through Therapists.plus helpful for worry, grief or adjusting to change. These can complement medical care and do not replace it. Your transplant team can help you decide what support fits.
Somatic Experiences: nervous system regulation →Somatic Experiences: embodiment and movement →Therapists.plus: mind body connection →
Keep in mind
- Serious conditions such as cancers and blood disorders should be guided by licensed professionals, and only a licensed clinician can decide what is appropriate after an evaluation.
- Unapproved stem cell products injected into joints, skin, the eye or the spine have been linked to reported risks including infection, immune reaction, tumor formation at the injection site and permanent injury, especially in the eye or spine.
- Blood-forming transplants are FDA-approved for certain cancers and blood disorders, but that approval does not extend to other marketed stem cell uses.
- For emergencies call 911; in a crisis call or text 988.
The one clearly FDA-approved use of stem cells for most people: blood-forming stem cell transplants from cord blood or bone marrow, performed at hospitals and transplant centers under close medical supervision.
Providers
We’re welcoming founding providers for blood-forming stem cell transplants now. Get matched or list your practice.
Frequently asked questions
What does stem cell therapy safety mean?
Stem cell therapy safety means knowing what is FDA-approved, understanding the risks and choosing a qualified, transparent provider. The clearly approved use is blood-forming stem cell transplants from cord blood or bone marrow for certain cancers and blood disorders. Products marketed for joints, back pain, skin, anti-aging or hair loss are generally not approved for those uses.
Are bone marrow and cord blood transplants FDA-approved?
Yes, blood-forming stem cell transplants from bone marrow or cord blood are FDA-approved for certain cancers and blood disorders. They are done at hospitals and transplant centers under close medical supervision. A licensed transplant physician decides whether one is appropriate for a particular person.
What are the red flags of an unsafe stem cell clinic?
Warning signs include guarantees of results, 'cure' or 'regrow' language, refusing to name the product or its FDA status, pressure to decide quickly and discouraging a second opinion. Any of these is a reason to pause and seek another opinion. The FDA has warned the public about unapproved stem cell clinics and products.
What should informed consent include?
Informed consent should cover the exact product and its FDA status, specific risks, the realistic chance of benefit, alternatives including doing nothing, total cost disclosure and your right to walk away. Use this as a checklist of things to ask. This page is not a consent form, and your provider supplies the actual consent process.
Is it safe to get stem cell treatment abroad?
Treatment abroad is materially higher risk because safety, sourcing and regulatory standards differ, and a complication is harder to address from a distance. A vetted domestic provider is a safer first step. You can also look for a registered clinical trial on ClinicalTrials.gov as a route to legitimate experimental care.
How do I report a problem with a stem cell product or clinic?
You can report a suspected problem through the FDA's MedWatch safety reporting program and with your state medical board. Keep records of the product, the provider and what happened. If you have a medical emergency, call 911 first.
Educational resource. Safe Stem Cells shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.